Quick Answer
Decoy Therapeutics Inc. reported Net Income of -$12.52 million for fiscal year 2025.
Decoy Therapeutics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$12.52M | -124.5% |
| 2024 | -$5.58M | +55.5% |
| 2023 | -$12.54M | +60.3% |
| 2022 | -$31.61M | -147.6% |
| 2021 | -$12.77M | -73.7% |
| 2020 | -$7.35M | -6.0% |
| 2019 | -$6.94M | -315.4% |
| 2018 | -$1.67M | +95.2% |
| 2017 | -$34.43M | +12.8% |
| 2016 | -$39.49M | -35.5% |
| 2015 | -$29.14M | -31328.7% |
| 2014 | -$92.7K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$873.5K | +10.1% | +8.8% |
| June 30, 2025 | -$957.8K | +32.8% | +44.0% |
| March 31, 2025 | -$1.71M | +0.3% | -75.9% |
| September 30, 2024 | -$972.1K | +60.2% | +31.8% |
| June 30, 2024 | -$1.42M | +63.3% | +17.0% |
| March 31, 2024 | -$1.72M | +67.9% | +29.8% |
| September 30, 2023 | -$2.44M | +83.0% | +37.0% |
| June 30, 2023 | -$3.88M | +17.8% | +27.4% |
- Decoy Therapeutics Inc. showed a decrease of -124.5% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Decoy Therapeutics Inc.’s net income has declined by 13400.9% (from -$92.7 thousand to -$12.52 million).
- The most recent figure is from Decoy Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: